Certara Global Health (CGH) harnesses cutting-edge methodologies like quantitative systems pharmacology (QSP), physiologically-based pharmacokinetics (PBPK), innovative clinical trial designs, and real-world evidence models to accelerate drug discovery and optimize patient outcomes. By applying model-informed translational medicine and pioneering regulatory science, CGH ensures critical therapies are both accessible and impactful.
Global Health
Advancing global health solutions in life sciences
We unite expertise, technology, and partnerships to accelerate life-saving medicines, ensuring global access to effective and affordable therapies.
Discover how Certara Global Health transforms drug development
Advancing affordable therapies for global populations
Innovative drug development
Integrating mechanistic modeling and screening technologies to enhance lead optimization and dosing strategies.
Streamlined portfolio management
Supporting asset due diligence and stage-gate decisions for targeted drug development.
Scalable best practices
Developing technologies and processes that improve quality and scale innovation across healthcare systems.
Expert collaboration
Partnering with global health experts to create sustainable healthcare impact.
A forward-thinking approach to Global Health life sciences
Explore Certara Global Health Solutions
Mechanistic modeling solutions
Optimizing drug discovery and lead selection with QSP and PBPK modeling.
Model-informed medicine
Enhancing translational development with innovative approaches.
Clinical pharmacology & translational medicine
Leveraging model-informed integrated drug development principles and stewardship through all phases of drug development.
Regulatory science expertise
Accelerating regulatory approvals worldwide.
CMC excellence
Ensuring delivery of high-quality medicines.
The Certara Global Health team
1 / 3
Experts
Kevin Hershberger, BPharm, MBA
Vice President, Certara Drug Development Solutions
25+ years of pharma project leadership and cross-functional program management experience.
Connect
2 / 3
Experts
David Wesche, MD, PhD
Vice President, Clinical Pharmacology, Certara Drug Development Solutions
Connect
3 / 3
Experts
Karen Rowland Yeo, PhD
SVP, Client & Regulatory Strategy
Karen has over 20 years of experience in applying PBPK modeling in global health and drug development settings across many therapeutic areas. She has over 100 publications and also serves as the Deputy-Editor-in-Chief of the CPT: Pharmacometrics & Systems Pharmacology journal.
ConnectStart a conversation with Certara Global Health
Certara Global Health is dedicated to delivering actionable solutions to accelerate the development of affordable medicines. Reach out to our team to explore how our expertise can benefit your organization and the populations you serve.
Proven expertise in global health innovation
Advanced technologies for drug development
Commitment to sustainable healthcare impact
Send an inquiry
Unlock the full potential of Certara solutions
Frequently Asked Questions
What is Certara Global Health's mission?
To accelerate the development of affordable, impactful therapies for underserved populations.
How does CGH utilize modeling and simulation?
By employing QSP and other methodologies to optimize drug discovery and development.
What sectors does Certara collaborate with?
CGH partners with global health organizations, regulatory agencies, and pharmaceutical innovators worldwide.
